{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:37:53Z","timestamp":1770813473596,"version":"3.50.1"},"reference-count":93,"publisher":"American Chemical Society (ACS)","issue":"4","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACS Infect. Dis."],"published-print":{"date-parts":[[2020,4,10]]},"DOI":"10.1021\/acsinfecdis.9b00469","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T14:59:25Z","timestamp":1582556365000},"page":"662-671","source":"Crossref","is-referenced-by-count":16,"title":["Macrofilaricides: An Unmet Medical Need for Filarial Diseases"],"prefix":"10.1021","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8930-1533","authenticated-orcid":true,"given":"Natalie A.","family":"Hawryluk","sequence":"first","affiliation":[{"name":"Bristol-Myers Squibb, Global Health, 10300 Campus Point Drive, San Diego, California 92121, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1016\/0001-706X(91)90015-C"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00456-16"},{"issue":"40","key":"ref3\/cit3","first-page":"594","volume":"92","author":"WHO","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.2147\/RRTM.S125204"},{"key":"ref5\/cit5","unstructured":"PAHO Disease Elimination Initiative: A Policy for an Integrated Sustainable\nApproach to Communicable Diseases in the Americas. https:\/\/www.paho.org\/hq\/index.php?option=com_docman&view=download&alias=49679-cd57-7-e-disease-elimination-initiative&category_slug=cd57-en&Itemid=270&lang=en (accessed November 24, 2019)."},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-019-0593-x"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2017.02.004"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-014-3969-7"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002839"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706854"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30467-4"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005163"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.05.003"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70139-X"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2.S1.S63"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2015.02.023"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2008.03.002"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011146.pub2"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182013001108"},{"issue":"4","key":"ref20\/cit20","first-page":"533","volume":"3","author":"Hoerauf A.","year":"2002","journal-title":"Curr. Opin Investig Drugs"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-308X(05)60004-8"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-5-12"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1086\/586753"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12084"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200112000-00011"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.2000.11813605"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02095-X"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000660"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2014.09.001"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu1152"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-007-0072-z"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(03)00026-1"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1002\/9783527652969.ch15"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04581-5"},{"key":"ref35\/cit35","doi-asserted-by":"crossref","unstructured":"AWOL. https:\/\/awol.lstmed.ac.uk\/ (accessed November 11, 2019).","DOI":"10.3390\/w11112201"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005156"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_454_17"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav3523"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1038\/207417a0"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-008-1133-y"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1710845114"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00322-5"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01995-13"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007159"},{"key":"ref45\/cit45","volume-title":"Tylosin Analogs As Anti-Filarial Agents: Medicinal Chemistry Optimization and Candidate Selection","author":"Von Geldern T. W.","year":"2017"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau2086"},{"key":"ref47\/cit47","volume-title":"Anti-Wolbachia Candidate ABBV-4083: Phase 1 Safety and Pharmacokinetics Clinical Trial in Healthy Adults","author":"Alami N. N.","year":"2019"},{"key":"ref48\/cit48","unstructured":"DNDi\nTylAMac (ABBV-4083). https:\/\/www.dndi.org\/diseases-projects\/portfolio\/abbv-4083\/ (accessed November 24, 2019)."},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2013.08.010"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis341"},{"key":"ref51\/cit51","volume-title":"Corallopyronin A: an effective antiwolbachial compound for the treatment of filarial infections and antibiotic for antimicrobial resistant STIs","author":"Pfarr K.","year":"2018"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1816585116"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed4030108"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2019.12.001"},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.38.7.555"},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.37.9.570"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01854"},{"key":"ref58\/cit58","unstructured":"U.S. FDA Approves Moxidectin For The Treatment Of River\nBlindness. https:\/\/www.prnewswire.com\/news-releases\/us-fda-approves-moxidectin-for-the-treatment-of-river-blindness-300666114.html (accessed February 27, 2020)."},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-017-2431-y"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2016.04.002"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1179\/000349804225021370"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32844-1"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002838"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.1586\/eri.11.30"},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2004.00616.x"},{"key":"ref66\/cit66","unstructured":"Johnson & Johnson Joins Public and Private\nPartners in the Largest Coordinated Action to Date to Eliminate or\nControl Neglected Tropical Diseases. https:\/\/www.jnj.com\/media-center\/press-releases\/johnson-johnson-joins-public-and-private-partners-in-the-largest-coordinated-action-to-date-to-eliminate-or-control-neglected-tropical-diseases, 2012."},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006787"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006320"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006436"},{"key":"ref70\/cit70","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/gev070"},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2014.06.009"},{"key":"ref72\/cit72","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2012.12.004"},{"key":"ref73\/cit73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007026"},{"key":"ref74\/cit74","unstructured":"H\u00fcbner, M. P., Sabine Specht, C. M., Koschel, M., Dubben, B., Frohberger, S. J., Ehrens, A., Fendler, M., Struever, D., Vallarino-Lhermitte, N., Gokool, S., Townson, S., Hoerauf, A., and Scandale, I. (2018) In  Oxfendazole treatment has a macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca gutturosa adult worm motility in vitro, ASTMH, 67th Annual Meeting."},{"key":"ref75\/cit75","unstructured":"DNDi Oxfendazole. https:\/\/www.dndi.org\/diseases-projects\/portfolio\/oxfendazole\/ (accessed November 24, 2019)."},{"key":"ref76\/cit76","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.9b00397"},{"key":"ref77\/cit77","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.9b00396"},{"key":"ref78\/cit78","unstructured":"Zhang, Y.K., Zhou, H., Ding, C., Plattner, J. J., and Freund, Y. Boron-containing small molecules as antihelminth agents. WO2011063293A1, 2011."},{"key":"ref79\/cit79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004062"},{"key":"ref80\/cit80","unstructured":"DNDi. First in Man Clinical Trial of Emodepside (BAY 44-4400),\nNCT02661178; clinicaltrials.gov, 2016."},{"key":"ref81\/cit81","volume-title":"A Single-Center, First-In-Human, Randomized, Double-Blind, Placebo-Controlled, Parallel-group Study To Investigate The Safety, Tolerability And Pharmacokinetics Of Escalating Single Doses Of Emodepside (BAY44\u20134400) In Healthy Male Subjects","author":"Gillon J. Y. A.","year":"2018"},{"key":"ref82\/cit82","unstructured":"DNDi Emodepside. https:\/\/www.dndi.org\/diseases-projects\/portfolio\/emodepside\/ (accessed November 24, 2019)."},{"key":"ref83\/cit83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003534"},{"key":"ref84\/cit84","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1983.tb03277.x"},{"key":"ref85\/cit85","doi-asserted-by":"publisher","DOI":"10.1051\/parasite\/2008153510"},{"key":"ref86\/cit86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2019.06.002"},{"key":"ref87\/cit87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2012.04.001"},{"key":"ref88\/cit88","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2005.73.234"},{"key":"ref89\/cit89","doi-asserted-by":"publisher","DOI":"10.1017\/S003118200700008X"},{"key":"ref90\/cit90","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06899-4"},{"key":"ref91\/cit91","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.76.67"},{"key":"ref92\/cit92","volume-title":"Antibiotics as anti-filarial drugs","author":"Sakanari J.","year":"2019"},{"key":"ref93\/cit93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007636"}],"container-title":["ACS Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.9b00469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T22:03:42Z","timestamp":1681769022000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acsinfecdis.9b00469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,10]]}},"alternative-id":["10.1021\/acsinfecdis.9b00469"],"URL":"https:\/\/doi.org\/10.1021\/acsinfecdis.9b00469","relation":{},"ISSN":["2373-8227","2373-8227"],"issn-type":[{"value":"2373-8227","type":"print"},{"value":"2373-8227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]}}}